LENSAR, INC. Stock-Based Compensation
LENSAR, INC. (LNSR) reported Stock-Based Compensation of $1.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- LENSAR, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $347.00K, a 54.70% decline year-over-year.
- LENSAR, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $690.00K, a 5.50% increase year-over-year.
- LENSAR, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $873.00K, a 31.87% increase year-over-year.
- LENSAR, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $850.00K, a 27.25% increase year-over-year.
- LENSAR, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $3.14M, a 17.94% increase from fiscal 2024.
- LENSAR, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $2.67M, a 51.89% decline from fiscal 2023.
- LENSAR, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $5.54M, a 16.22% decline from fiscal 2022.
- LENSAR, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $6.61M, a 3.71% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $347.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.04M 10-Q · filed 2026-08-13 | $1.91M derived: sum of 3 quarters · filed 2026-08-13 | $2.76M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $690.00K 10-Q · filed 2026-05-08 | $1.56M derived: sum of 2 quarters · filed 2026-05-08 | $2.41M derived: sum of 3 quarters · filed 2026-05-08 | $3.18M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $873.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.72M derived: sum of 2 quarters · filed 2026-03-31 | $2.49M derived: sum of 3 quarters · filed 2026-08-13 | $3.14M 10-K · filed 2026-03-31 |
| 2025-09-30 | $850.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.62M derived: sum of 2 quarters · filed 2026-08-13 | $2.27M 10-Q · filed 2025-11-06 | $2.93M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $766.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.42M 10-Q · filed 2026-08-13 | $2.08M derived: sum of 3 quarters · filed 2026-08-13 | $2.75M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $654.00K 10-Q · filed 2026-05-08 | $1.32M derived: sum of 2 quarters · filed 2026-05-08 | $1.98M derived: sum of 3 quarters · filed 2026-05-08 | $2.67M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $662.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.33M derived: sum of 2 quarters · filed 2026-03-31 | $2.01M derived: sum of 3 quarters · filed 2026-03-31 | $2.67M 10-K · filed 2026-03-31 |
| 2024-09-30 | $668.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.35M derived: sum of 2 quarters · filed 2025-11-06 | $2.00M 10-Q · filed 2025-11-06 | $2.82M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $683.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.33M 10-Q · filed 2025-08-07 | $2.15M derived: sum of 3 quarters · filed 2025-08-07 | $3.32M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $652.00K 10-Q · filed 2025-05-08 | $1.47M derived: sum of 2 quarters · filed 2025-05-08 | $2.64M derived: sum of 3 quarters · filed 2025-05-08 | $4.46M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $816.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.99M derived: sum of 2 quarters · filed 2025-02-27 | $3.81M derived: sum of 3 quarters · filed 2025-02-27 | $5.54M 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.00M derived: sum of 2 quarters · filed 2024-11-07 | $4.72M 10-Q · filed 2024-11-07 | $6.42M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.55M 10-Q · filed 2024-08-08 | $5.25M derived: sum of 3 quarters · filed 2024-08-08 | $6.92M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.73M 10-Q · filed 2024-05-09 | $3.42M derived: sum of 2 quarters · filed 2024-05-09 | $5.09M derived: sum of 3 quarters · filed 2024-05-09 | $6.73M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $3.37M derived: sum of 2 quarters · filed 2024-03-04 | $5.00M derived: sum of 3 quarters · filed 2024-03-04 | $6.61M 10-K · filed 2024-03-04 |
| 2022-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.31M derived: sum of 2 quarters · filed 2023-11-09 | $4.92M 10-Q · filed 2023-11-09 | $6.46M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.24M 10-Q · filed 2023-08-09 | $4.79M derived: sum of 3 quarters · filed 2023-08-09 | $6.36M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $1.61M 10-Q · filed 2023-05-15 | $3.15M derived: sum of 2 quarters · filed 2023-05-15 | $4.72M derived: sum of 3 quarters · filed 2023-05-15 | $6.15M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.12M derived: sum of 2 quarters · filed 2023-03-16 | $4.55M derived: sum of 3 quarters · filed 2023-03-16 | $6.87M 10-K · filed 2023-03-16 |
| 2021-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.00M derived: sum of 2 quarters · filed 2022-11-09 | $5.32M 10-Q · filed 2022-11-09 | $10.46M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.75M 10-Q · filed 2022-08-08 | $8.88M derived: sum of 3 quarters · filed 2022-08-08 | $12.76M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $2.32M 10-Q · filed 2022-05-09 | $7.46M derived: sum of 2 quarters · filed 2022-05-09 | $11.33M derived: sum of 3 quarters · filed 2022-05-09 | $11.33M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $5.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $9.01M derived: sum of 2 quarters · filed 2022-03-03 | $9.01M derived: sum of 3 quarters · filed 2022-03-03 | $9.04M 10-K · filed 2022-03-03 |
| 2020-09-30 | $3.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $3.87M derived: sum of 2 quarters · filed 2021-11-08 | $3.91M 10-Q · filed 2021-11-08 | $3.94M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $38.00K 10-Q · filed 2021-08-06 | $67.00K derived: sum of 3 quarters · filed 2021-08-06 | |
| 2020-03-31 | $38.00K 10-Q · filed 2021-05-06 | $67.00K derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $102.00K 10-K · filed 2021-03-12 | ||
| 2019-09-30 | $73.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |